Insmed (INSM) Return on Sales [ROS] (2009 - 2026)
Insmed (INSM) recorded Return on Sales [ROS] of -0.36% in Q2 2026, up 290.91 percentage points from -291.28% a year earlier and up 49.75 percentage points from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
On a TTM basis, Insmed's Return on Sales [ROS] came in at -73.89% as of Jun 30, 2026, up 178.52 percentage points year-over-year; for FY2025, it was -205.59%, up 35.88 percentage points from FY2024.
- Annual Return on Sales [ROS] has a five-year change of -44.27 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -241.47% in FY2024 (-8.97 pp), -232.51% in FY2023 (-46.12 pp), -186.39% in FY2022 (+12.64 pp) and -199.03% in FY2021 (-37.71 pp).
- The Q2 2026 figure is the highest quarterly Return on Sales [ROS] in data going back to Q2 2010.
- On a year-over-year basis, Return on Sales [ROS] has increased for three consecutive quarters, with an average year-over-year change of +60.44 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 290.91 percentage points in Q2 2026, against a drop of 169.56 percentage points in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -50.11% (Q1 2026), -121.19% (Q4 2025) and -257.13% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Insmed | 26.21 Bn | 21.25 Bn | 446.21 Mn | -17.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -17.04% |
| Jun 30, 2026 | -0.36% |
| Mar 31, 2026 | -50.11% |
| Dec 31, 2025 | -121.19% |
| Sep 30, 2025 | -257.13% |
| Jun 30, 2025 | -291.28% |
| Mar 31, 2025 | -267.33% |
| Dec 31, 2024 | -220.61% |
| Sep 30, 2024 | -228.45% |
| Jun 30, 2024 | -319.80% |
| Mar 31, 2024 | -192.72% |
| Dec 31, 2023 | -213.01% |
| Sep 30, 2023 | -186.75% |
| Jun 30, 2023 | -304.97% |
| Mar 31, 2023 | -227.19% |
| Dec 31, 2022 | -255.44% |
| Sep 30, 2022 | -188.54% |
| Jun 30, 2022 | -135.41% |
| Mar 31, 2022 | -169.15% |
| Dec 31, 2021 | -176.53% |
API Access
Insmed Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();